• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

beta-Lactam antibiotics: structural relationships affecting in vitro activity and pharmacologic properties.

作者信息

Neu H C

出版信息

Rev Infect Dis. 1986 Jul-Aug;8 Suppl 3:S237-59. doi: 10.1093/clinids/8.supplement_3.s237.

DOI:10.1093/clinids/8.supplement_3.s237
PMID:3529320
Abstract

The essential nucleus of beta-lactam antibiotics is the four-membered ring, which can exist fused to form bicyclic ring structures or with moieties alone affixed to the four atoms. Penicillins, penems, carbapenems, and clavams have asymmetric centers at C-5 and C-6; cephalosporins and oxacephems have asymmetric centers at C-6 and C-7. Penicillins, cephalosporins, and monobactams require a beta-acylamino group for antimicrobial activity. Cephalosporins can undergo modification at C-3 and C-7 in both the alpha and beta position. Sulfur can be replaced with oxygen to achieve a more reactive nucleus. The most useful 7-beta-acylamino groups have been a 2-aminothiazolyl and an iminomethoxy or carboxypropyl group. Substitutions on the 7-alpha position increase beta-lactamase stability but decrease activity against staphylococci and Streptococcus pneumoniae. C-3 substitutions, particularly pyridinium groups, increase activity against Pseudomonas aeruginosa and Staphylococcus aureus. Carbapenems possess 6-alkyl substitutions in a trans configuration and inhibit aerobic, anaerobic gram-positive, and gram-negative bacteria. Monobactams are activated by sulfonic, phosphoric, or carboxyl groups, and their properties are related to the C-3-acyl side chain and their beta-lactamase stability to the C-4 grouping. beta-Lactamase inhibitors acylated by beta-lactamases can be penicillanic acid derivatives or clavulanates.

摘要

相似文献

1
beta-Lactam antibiotics: structural relationships affecting in vitro activity and pharmacologic properties.
Rev Infect Dis. 1986 Jul-Aug;8 Suppl 3:S237-59. doi: 10.1093/clinids/8.supplement_3.s237.
2
Relation of structural properties of beta-lactam antibiotics to antibacterial activity.β-内酰胺类抗生素的结构特性与抗菌活性的关系。
Am J Med. 1985 Aug 9;79(2A):2-13. doi: 10.1016/0002-9343(85)90254-2.
3
Modern beta-lactam antibiotics.
Pharmacol Ther. 1985;29(3):321-52. doi: 10.1016/0163-7258(85)90007-5.
4
Structure activity relationships among the monobactams.
J Antimicrob Chemother. 1984 Oct;14(4):313-27. doi: 10.1093/jac/14.4.313.
5
beta-lactam antibiotics. II. Structure-activity relationships of 6-[alpha-(alpha'-ureido-acylamino) acylamino] penicillanic acids.
J Antibiot (Tokyo). 1978 Oct;31(10):1013-22. doi: 10.7164/antibiotics.31.1013.
6
β-Lactams and β-Lactamase Inhibitors: An Overview.β-内酰胺类与β-内酰胺酶抑制剂:概述
Cold Spring Harb Perspect Med. 2016 Aug 1;6(8):a025247. doi: 10.1101/cshperspect.a025247.
7
Synergism of PS-5 with penicillins and cephalosporins in antimicrobial activity against beta-lactam-resistant gram-negative microorganisms.
J Antibiot (Tokyo). 1984 Nov;37(11):1414-22. doi: 10.7164/antibiotics.37.1414.
8
[Nontraditional beta-lactam antibiotics].
Verh K Acad Geneeskd Belg. 1991;53(1):39-58; discussion 58-9.
9
Penicillin-binding proteins and beta-lactamases: their effects on the use of cephalosporins and other new beta-lactams.青霉素结合蛋白与β-内酰胺酶:它们对头孢菌素及其他新型β-内酰胺类药物使用的影响
Curr Clin Top Infect Dis. 1987;8:37-61.
10
Basic design of beta-lactam antibiotics: penams and analogues and monocyclic beta-lactams.β-内酰胺类抗生素的基本设计:青霉烷类及其类似物和单环β-内酰胺类
Scand J Infect Dis Suppl. 1984;42:38-49.

引用本文的文献

1
Convenient syntheses of 2-acylamino-4-halothiazoles and acylated derivatives using a versatile Boc-intermediate.使用通用的Boc中间体方便地合成2-酰氨基-4-卤代噻唑和酰化衍生物。
RSC Adv. 2024 Sep 2;14(38):27894-27903. doi: 10.1039/d4ra04959d. eCollection 2024 Aug 29.
2
Pharmacokinetic-pharmacodynamic analysis of cefmetazole against extended-spectrum β-lactamase-producing Enterobacteriaceae in dogs using Monte Carlo Simulation.使用蒙特卡洛模拟对头孢美唑针对犬体内产超广谱β-内酰胺酶肠杆菌科细菌进行药代动力学-药效学分析。
Front Vet Sci. 2023 Sep 28;10:1270137. doi: 10.3389/fvets.2023.1270137. eCollection 2023.
3
Betaxolol as a Potent Inhibitor of NDM-1-Positive That Synergistically Enhances the Anti-Inflammatory Effect in Combination with Meropenem.
β-受体阻滞剂贝他洛尔对产 NDM-1 阳性 的强效抑制作用,并与美罗培南联合增强抗炎作用。
Int J Mol Sci. 2023 Aug 29;24(17):13399. doi: 10.3390/ijms241713399.
4
In vitro efficacy of cephamycins against multiple extended-spectrum β-lactamase-producing Klebsiella pneumoniae, Proteus mirabilis, and Enterobacter cloacae isolates from dogs and cats.头孢菌素类药物对犬猫产多种超广谱β-内酰胺酶的肺炎克雷伯菌、奇异变形杆菌和阴沟肠杆菌的体外疗效。
J Vet Med Sci. 2023 Jun 13;85(6):653-656. doi: 10.1292/jvms.23-0052. Epub 2023 May 8.
5
The Blood-Brain Barrier and Pharmacokinetic/Pharmacodynamic Optimization of Antibiotics for the Treatment of Central Nervous System Infections in Adults.血脑屏障与治疗成人中枢神经系统感染抗生素的药代动力学/药效学优化
Antibiotics (Basel). 2022 Dec 19;11(12):1843. doi: 10.3390/antibiotics11121843.
6
uCARE Chem Suite and uCAREChemSuiteCLI: Tools for bacterial resistome prediction.uCARE化学套件和uCARE化学套件命令行界面:用于细菌耐药基因组预测的工具。
Genes Dis. 2020 Jun 30;8(5):721-729. doi: 10.1016/j.gendis.2020.06.008. eCollection 2021 Sep.
7
β-Lactamases and β-Lactamase Inhibitors in the 21st Century.β-内酰胺酶与β-内酰胺酶抑制剂:21 世纪的挑战
J Mol Biol. 2019 Aug 23;431(18):3472-3500. doi: 10.1016/j.jmb.2019.04.002. Epub 2019 Apr 5.
8
Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli.头孢地尔:一种具有抗碳青霉烯类和多药耐药革兰氏阴性杆菌活性的铁载体头孢菌素。
Drugs. 2019 Feb;79(3):271-289. doi: 10.1007/s40265-019-1055-2.
9
Ceftazidime/avibactam: a novel cephalosporin/nonbeta-lactam beta-lactamase inhibitor for the treatment of complicated urinary tract infections and complicated intra-abdominal infections.头孢他啶/阿维巴坦:一种用于治疗复杂性尿路感染和复杂性腹腔内感染的新型头孢菌素/非β-内酰胺类β-内酰胺酶抑制剂。
Drug Des Devel Ther. 2016 Jul 26;10:2379-86. doi: 10.2147/DDDT.S110946. eCollection 2016.
10
Ceftazidime-avibactam: an evidence-based review of its pharmacology and potential use in the treatment of Gram-negative bacterial infections.头孢他啶-阿维巴坦:基于证据对其药理学及治疗革兰氏阴性菌感染潜在用途的综述
Core Evid. 2014 Jan 24;9:13-25. doi: 10.2147/CE.S40698. eCollection 2014.